Resumen

SESMA PARDO, Eva; FINKLE, Joshua; GONZALEZ TORRES, Miguel Ángel  y  GAVIRIA, Moisés. Perimenopausal depression: a review. Rev. Asoc. Esp. Neuropsiq. [online]. 2013, vol.33, n.120, pp.681-691. ISSN 2340-2733.  https://dx.doi.org/10.4321/S0211-57352013000400002.

From adolescence, women have a 1.5 to 3 times higher risk than men of suffering from a depressive disorder. This risk increases in the transition period to menopause or perimenopause, when the depressive vulnerability becomes especially intense. Hormonal, psychological and sociocultural factors have been suggested to understand the etiopathogeny of these disorders. Treatment of depression in perimenopause is determined by clinical severity and includes antidepressants, psychotherapy, and sometimes, hormone replacement therapy with estrogens. Perimenopausal depression is an underdiagnosed and poorly treated problem, which generates a high level of suffering and deserves greater attention by clinicians and health systems.

Palabras clave : Depression; Perimenopause; Estrogens.

        · resumen en Español     · texto en Español     · Español ( pdf )